glp-1 for addiction medications get at the heart of addiction: study – WashU Medicine Obesity drug cuts opiate craving

We also acknowledge that the requirement for smartphone or tablet access and the monthly subscription fee (the services require payment) may exclude individuals from lower socioeconomic backgrounds or older adults less comfortable with technology, potentially exacerbating health disparities

novembre 2023;36(11)

Leanne H

I think that potential is there for positive impact, but there are not enough studies yet. Novo Nordisk, which makes Wegovy, doesnt encourage off-label use of its obesity medications

Second, consider how alcohol interacts with diabetes management

The study showed that orforglipron led to significant weight changes in participants, especially at the highest dose